To access this element change to forms mode OFF
Grant Award View - GA82040
Natural Killer Cell Cancer Immunotherapy
GA ID:
GA82040
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
20-Apr-2020
Publish Date:
11-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jan-2021 to 31-Dec-2025
Value (AUD):
$2,238,220.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Natural Killer Cell Cancer Immunotherapy
Purpose:
Natural killer (NK) cell posses the ability to detect and kill transformed or stressed cells such as tumour cells. My recent data show that NK cells are required for efficient immunotherapy responses by enhancing the global immune response to cancer and preventing tumour cells from metastasising to vital organs. I propose to identify novel pathways and develop new therapeutic approaches to exploit NK cell anti-tumor function and improve cancer immunotherapy response rates in patients.
GO ID:
GO Title:
Investigator Grants 2020
Internal Reference ID:
GNT1195296
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA